T5 exonuclease-CAS12J fusion

T5 exonuclease-CAS12J fusion has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Mar 13, 2026: “Characterization and engineering of highly efficient Cas12j genome editors”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on T5 exonuclease-CAS12J fusion

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: King Abdullah University of Science and Technology
  • Cells1

What did studies of T5 exonuclease-CAS12J fusion find?

1

Studies of T5 exonuclease-CAS12J fusion measured one outcome, genome editing efficiency.

Genome editing efficiency

upin mammalian cells1

1 study
  1. T5 exonuclease-CAS12J fusion increases genome editing efficiency in mammalian cells across multiple mammalian cell types.

    “We therefore engineered T5 exonuclease-Cas12j fusions, resulting in substantially enhanced genome-editing activity across multiple mammalian cell types”

    Cellsacross multiple mammalian cell types

    Characterization and engineering of highly efficient Cas12j genome editors

    Trends in biotechnology

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months